Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Selected Data About Geographic Locations

Selected Data About Geographic Locations

Geographic Information Systems (GIS) rely on two core types of data: spatial data and attribute data.Spatial DataSpatial data defines the physical location of features within a coordinate system, typically expressed in terms of latitude and longitude. It provides precise positioning for elements like roads, rivers, or buildings.Attribute DataAttribute data complements spatial data by adding descriptive information about these features. For example, a road's spatial data includes its start and...

Protein Kinases and Phosphatases

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

Protein Kinases and Phosphatases

Protein Kinases and Phosphatases

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Eukaryotic Transcription Inhibitors

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Explainable artificial intelligence reveals divergent learning in pharmacophore-based hierarchical pooling graph neural networks.

Scientific reports·2026

Same author

Computational Identification of Active Drug Metabolites for Human Protein Targets.

Molecular pharmaceutics·2026

Same author

CRUSH-Cleavage Rules Using SMIRKS Heuristics: an enhanced molecular fragmentation algorithm.

Journal of cheminformatics·2026

Same author

Categorization of Protein Kinases by Combining Data from Cell Biology and Medicinal Chemistry Enables Further Evaluation and Differentiation of the Understudied Kinome.

Journal of medicinal chemistry·2026

Same author

Explainable artificial intelligence for molecular design in pharmaceutical research.

Chemical science·2026

Same author

Transformer Learning in Sequence-Based Drug Design Depends on Compound Memorization and Similarity of Sequence-Compound Pairs.

Molecular informatics·2026

Same journal

SpaceExpander: An Automated System for Drafting Markush Claims to Expand Chemical Space.

Molecular informatics·2026

Same journal

A Structure-Informed Atlas of Venom-Derived Peptides Reveals the Organization of Chemical Space.

Molecular informatics·2026

Same journal

ConGen: Targeted Molecule Generation Through Contrastive Learning and Latent Optimization.

Molecular informatics·2026

Same journal

Novel Molecules Generation Using Graph Generative Adversarial Networks.

Molecular informatics·2026

Same journal

An Attention-Driven Graph Transformer With Nonlinear Modeling and Neuro-Fuzzy Fusion for High-Order Toxic Molecular Graph Learning.

Molecular informatics·2026

Same journal

Molecular Modeling and Chemoinformatics in Ukraine.

Molecular informatics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 12, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Evaluation of Kinase Inhibitor Selectivity Using Cell-based Profiling Data.

Filip Miljković¹, Jürgen Bajorath¹

¹Department of Life Science Informatics Bonn-Aachen International Center for Information Technology, Rheinische Friedrich-Wilhelms-Universität Bonn, Endenicher Allee 19c, D-53115, Bonn, Germany.

Molecular Informatics

|March 31, 2018

Summary

This summary is machine-generated.

This study analyzes kinase inhibitor data, revealing opportunities for data-driven drug discovery. Computational analysis identified selective kinase inhibitors by examining their activity profiles against paired kinases.

Keywords:

Protein kinases compound data mining drug targets kinase inhibitors profiling data selectivity

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

Related Experiment Videos

Last Updated: Feb 12, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

Area of Science:

Biochemistry
Pharmacology
Medicinal Chemistry

Background:

Kinases are crucial drug targets, with inhibitors forming a key therapeutic strategy.
Kinase inhibitor data is growing rapidly, presenting both computational challenges and opportunities.
Understanding kinase inhibitor selectivity is vital for effective drug development.

Purpose of the Study:

To evaluate publicly available kinase inhibitor data.
To computationally explore the selectivity of clinical kinase inhibitors.
To identify selective and uniquely selective kinase inhibitors.

Main Methods:

Analysis of publicly available kinase inhibitor datasets.
Computational profiling of clinical kinase inhibitors using cell-based data.
Generation of uni-directional and bi-directional selectivity profiles for kinase inhibitor pairs.

Main Results:

Characterization of various kinase inhibitor properties.
Identification of numerous selective kinase inhibitors.
Discovery of compounds with uni-directional and inverted bi-directional selectivity.

Conclusions:

Kinase inhibitor big data offers significant potential for medicinal chemistry.
Computational selectivity profiling can identify promising drug candidates.
Understanding selectivity profiles is key to targeted kinase inhibition therapies.